Study questions worth of ultrasound and removing benign ovarian cysts in preventing cancer
This article was originally published in Clinica
A 15-year study of over 5,000 women in the UK has shown for the first time that removing benign ovarian cysts does not reduce a woman's chance of dying from ovarian cancer. The study has also questioned the value of ultrasound as a cost-effective screening tool for the disease.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.